Navigation Links
Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Date:8/20/2007

PALATINE, IL, Aug. 20 /PRNewswire-FirstCall/ -- Acura Pharmaceuticals, Inc. (OTC Bulletin Board: ACUR) (the "Company") today announced it has entered into a Securities Purchase Agreement (the "Agreement"), with an investor group comprised of Vivo Ventures Fund VI L.P., Vivo Ventures Fund VI Affiliates Fund, L.P., GCE Holdings LLC and certain individual investors (the "Investors"). Pursuant to the Agreement, the Investors purchased 23,605,551 Units ("Units") at a price of $1.08 per Unit with each Unit consisting of four shares of the Company's common stock, $0.01 par value, and a warrant to purchase one share of common stock. 13,842,590 of the Units were purchased for cash, with the balance of 9,962,961 Units issued in consideration for the conversion of all of the Company's $10.544 million in outstanding bridge loan indebtedness. Net cash proceeds to the Company, after expenses relating to closing the transaction, are estimated to be approximately $14.5 million.

As a condition to the Agreement, the Company's 2004 Note in the principal amount of $5.0 million was amended to, among other things, extend the maturity date to December 31, 2008 from September 30, 2007 and to set the interest rate at 10% from the prior rate of prime rate plus 4.5% (currently 12.75%). A more detailed description of this equity financing may be reviewed in the Company's Form 8-K filed with the Securities and Exchange Commission.

Use of Proceeds

The Company will utilize a portion of the net proceeds from the transaction described above to fund Study 105, the pivotal phase 3 trial for OxyADF (oxycodone HCl and niacin) Tablets, its lead product candidate utilizing Aversion(R) Technology. Study 105 is a randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of the safety and efficacy of OxyADF Tablets for the treatment of acute, moderate to severe postoperative pain following bunionectomy surgery in adult patients. This is a 3-arm clinical trial comp
'/>"/>

SOURCE Acura Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
2. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
3. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer
4. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data at Society Of Nuclear Medicine 2007 Annual Meeting
5. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
6. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
7. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
8. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
9. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
10. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
11. Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 22 2015 /CNW/ - The Taskforce representing Canada,s ... all the hard work that the Minister and Health Canada ... This program recognizes the needs of the thalidomide survivors, and ... a year, tax free, with annual adjustments for inflation. ... annual payments of $100,000 based on the severity of their ...
(Date:5/22/2015)... 22, 2015  Effective staffing of key marketing ... and success. Research and consulting ... provide pharmaceutical and biotech marketing managers with metrics ... that are being channeled into marketing operations of ... can utilize this report to benchmark their own ...
(Date:5/22/2015)... , May 22, 2015 The leading ... $13 billion global cardiac rhythm management device market ... found that Medtronic, St. Jude Medical, Boston Scientific ... of this market segment. The healthcare market research ... , uses 2015 as a base year, providing ...
Breaking Medicine Technology:Effective Marketing Services Group Critical for Pharmaceutical Brand Recognition 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4
(Date:5/25/2015)... 24Hr HomeCare is proud to announce that David Allerby, ... Ryan Iwamoto, Co-Founder & CMO, are Finalists for the ... in Greater Los Angeles. The award is presented by ... performance, and a personal commitment to their communities. , ... success of our organization,” said Co-Founder & CEO, David ...
(Date:5/25/2015)... ProDrop Light Show allows users to now have ... a click of a mouse. Users have full control over angle ... Cut Pro X. , ProDrop Light Show gives users 30 fully ... much more leaving infinite possibilities all within Final Cut Pro X. ... presets, users can apply their very own media files or text ...
(Date:5/25/2015)... May 25, 2015 Decora Preset 60 ... is now available on ‘The Hardware City.’ The product helps ... to set a time and the related electronic device is ... a representative of the company said, “We are glad that ... Now customers can buy Countdown Timer Switch in just a ...
(Date:5/24/2015)... May 24, 2015 Women’s Excellence ... take pressure measurements in patients’ bladder and urethra. This ... orders it if they have reported symptoms of stress ... , Women’s Excellence in Bladder Control is a comprehensive ... leakage or problems with overall control of their bladder. ...
(Date:5/24/2015)... Indiana Fiber Network, LLC (IFN), the leading ... America, Inc. (MTA) has selected IFN as a fiber ... Enterprise Sales Manager, fiber route diversity and network redundancy ... provides MTA with the diverse fiber transport from their ... and voice carriers located at Henry Street in Indianapolis, ...
Breaking Medicine News(10 mins):Health News:24Hr HomeCare Co-Founders Named Finalists for EY Entrepreneur of the Year 2015 Awards 2Health News:Developers at Pixel Film Studios Release of ProDrop Light Show for Final Cut Pro X. 2Health News:Leviton's Decora 60 Minute Countdown Timer Available On ‘The Hardware City’ 2Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2
... ... rigorous TRUSTe certification process and demonstrating its trustworthiness, Troubled Teens Wizard - a directory ... the TRUSTe Privacy Seal on its Web site. , ... Newport Beach, CA and San Francisco, CA (PRWEB) ...
... ... Change. , ... 4, 2010 -- Jumping On Water: Awaken Your Joy Empower Your Life, a ground-breaking new ... it here ., , ,When asked what Jumping On Water is all about? Karam explains, ...
... Rosemont Media™, a ... meeting with leaders from across the globe at one of the largest annual meetings of ... professionals from around the world to spend a few days presenting and learning about the ... ...
... ... Natural Products Expo West trade show to be held at the Anaheim Convention Center in ... ... product company headquartered in Los Angeles, CA, will be unveiling Ideal Bowel Support 299v® at ...
... ... iKey authenticator provide Euthymics with a streamlined electronic document exchange process. , ... (PRWEB) February ... and specialists in Digital Identities for securing PDF documents, has today announced the ...
... ... on Compulsive Gambling (FCCG) sees the effects that the most celebrated day in ... caller do. Many sports gamblers view this game as their last chance ... everything in hopes to achieve that “big win”. What many compulsive gamblers ...
Cached Medicine News:Health News:Troubled Teens Wizard Earns Coveted Truste Certification 2Health News:Troubled Teens Wizard Earns Coveted Truste Certification 3Health News:Jumping On Water Hits Amazon Bestseller List 2Health News:Jumping On Water Hits Amazon Bestseller List 3Health News:Plastic Surgery Website Design Firm Rosemont Media Heads to Miami for the 44th Annual Baker Gordon Symposium 2Health News:Plastic Surgery Website Design Firm Rosemont Media Heads to Miami for the 44th Annual Baker Gordon Symposium 3Health News:Jarrow Formulas, Inc. to Unveil Ideal Bowel Support (IBS) 299v at Upcoming Natural Products Expo West Show in Anaheim 2Health News:Euthymics Bioscience Collaborates with GlobalSign and SafeNet to Provide an FDA Approved Electronic Signature Solution 2Health News:Euthymics Bioscience Collaborates with GlobalSign and SafeNet to Provide an FDA Approved Electronic Signature Solution 3Health News:Euthymics Bioscience Collaborates with GlobalSign and SafeNet to Provide an FDA Approved Electronic Signature Solution 4Health News:Euthymics Bioscience Collaborates with GlobalSign and SafeNet to Provide an FDA Approved Electronic Signature Solution 5Health News:Super Bowl XLIV - When it's Not Just About the Game 2
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
Steroid-eluting, epicardial pacing leads...
Medicine Products: